133 related articles for article (PubMed ID: 37974463)
1. The cancer-associated glycosyltransferase GnT-V (MGAT5) recognizes the N-glycan core via residues outside its catalytic pocket.
Osuka RF; Nagae M; Ohuchi A; Ohno S; Yamaguchi Y; Kizuka Y
FEBS Lett; 2023 Dec; 597(24):3102-3113. PubMed ID: 37974463
[TBL] [Abstract][Full Text] [Related]
2. Recognition of glycan and protein substrates by N-acetylglucosaminyltransferase-V.
Hirata T; Nagae M; Osuka RF; Mishra SK; Yamada M; Kizuka Y
Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129726. PubMed ID: 32890705
[TBL] [Abstract][Full Text] [Related]
3. N-acetylglucosaminyltransferase-V requires a specific noncatalytic luminal domain for its activity toward glycoprotein substrates.
Osuka RF; Hirata T; Nagae M; Nakano M; Shibata H; Okamoto R; Kizuka Y
J Biol Chem; 2022 Mar; 298(3):101666. PubMed ID: 35104505
[TBL] [Abstract][Full Text] [Related]
4. Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V.
Nagae M; Kizuka Y; Mihara E; Kitago Y; Hanashima S; Ito Y; Takagi J; Taniguchi N; Yamaguchi Y
Nat Commun; 2018 Aug; 9(1):3380. PubMed ID: 30140003
[TBL] [Abstract][Full Text] [Related]
5. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V.
Lee JK; Matthews RT; Lim JM; Swanier K; Wells L; Pierce JM
J Biol Chem; 2012 Aug; 287(34):28526-36. PubMed ID: 22715095
[TBL] [Abstract][Full Text] [Related]
6. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
8. Shedding of N-acetylglucosaminyltransferase-V is regulated by maturity of cellular N-glycan.
Hirata T; Takata M; Tokoro Y; Nakano M; Kizuka Y
Commun Biol; 2022 Aug; 5(1):743. PubMed ID: 35915223
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional homology model of GlcNAc-TV glycosyltransferase.
Janoš P; Kozmon S; Tvaroška I; Koca J
Glycobiology; 2016 Jul; 26(7):757-771. PubMed ID: 26821880
[TBL] [Abstract][Full Text] [Related]
10. Substrate Preference and Interplay of Fucosyltransferase 8 and N-Acetylglucosaminyltransferases.
Tseng TH; Lin TW; Chen CY; Chen CH; Lin JL; Hsu TL; Wong CH
J Am Chem Soc; 2017 Jul; 139(28):9431-9434. PubMed ID: 28678517
[TBL] [Abstract][Full Text] [Related]
11. True significance of N-acetylglucosaminyltransferases GnT-III, V and α1,6 fucosyltransferase in epithelial-mesenchymal transition and cancer.
Taniguchi N; Ohkawa Y; Maeda K; Harada Y; Nagae M; Kizuka Y; Ihara H; Ikeda Y
Mol Aspects Med; 2021 Jun; 79():100905. PubMed ID: 33010941
[TBL] [Abstract][Full Text] [Related]
12. Examination of differential glycoprotein preferences of N-acetylglucosaminyltransferase-IV isozymes a and b.
Osada N; Nagae M; Nakano M; Hirata T; Kizuka Y
J Biol Chem; 2022 Sep; 298(9):102400. PubMed ID: 35988645
[TBL] [Abstract][Full Text] [Related]
13. Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells.
Guo HB; Zhang Y; Chen HL
J Cancer Res Clin Oncol; 2001 Apr; 127(4):231-6. PubMed ID: 11315257
[TBL] [Abstract][Full Text] [Related]
14. Altered β1,6-GlcNAc and bisecting GlcNAc-branched N-glycan on integrin β1 are associated with early spontaneous miscarriage in humans.
Zhang M; Wang M; Gao R; Liu X; Chen X; Geng Y; Ding Y; Wang Y; He J
Hum Reprod; 2015 Sep; 30(9):2064-75. PubMed ID: 26109616
[TBL] [Abstract][Full Text] [Related]
15. N-glycosylation by N-acetylglucosaminyltransferase IVa enhances the interaction of integrin β1 with vimentin and promotes hepatocellular carcinoma cell motility.
Yang D; Han F; Cai J; Sun H; Wang F; Jiang M; Zhang M; Yuan M; Zhou W; Li H; Yang L; Bai Y; Xiao L; Dong H; Cheng Q; Mao H; Zhou L; Wang R; Li Y; Nie H
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119513. PubMed ID: 37295747
[TBL] [Abstract][Full Text] [Related]
16. N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.
Kudo T; Nakagawa H; Takahashi M; Hamaguchi J; Kamiyama N; Yokoo H; Nakanishi K; Nakagawa T; Kamiyama T; Deguchi K; Nishimura S; Todo S
Mol Cancer; 2007 May; 6():32. PubMed ID: 17488527
[TBL] [Abstract][Full Text] [Related]
17. 3D Structure and Function of Glycosyltransferases Involved in
Nagae M; Yamaguchi Y; Taniguchi N; Kizuka Y
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936666
[TBL] [Abstract][Full Text] [Related]
18. The role of the GlcNAc(beta)1,2Man(alpha)- moiety in mammalian development. Null mutations of the genes encoding UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2 cause embryonic lethality and congenital muscular dystrophy in mice and men, respectively.
Schachter H
Biochim Biophys Acta; 2002 Dec; 1573(3):292-300. PubMed ID: 12417411
[TBL] [Abstract][Full Text] [Related]
19. N-Acetylglucosaminyltransferase IX acts on the GlcNAc beta 1,2-Man alpha 1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan.
Inamori K; Endo T; Gu J; Matsuo I; Ito Y; Fujii S; Iwasaki H; Narimatsu H; Miyoshi E; Honke K; Taniguchi N
J Biol Chem; 2004 Jan; 279(4):2337-40. PubMed ID: 14617637
[TBL] [Abstract][Full Text] [Related]
20. Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
de-Souza-Ferreira M; Ferreira ÉE; de-Freitas-Junior JCM
Cell Oncol (Dordr); 2023 Jun; 46(3):481-501. PubMed ID: 36689079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
